Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:579

Hypercholesterolemia Global Clinical Trials Review, Q2, 2011

Hypercholesterolemia Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Hypercholesterolemia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hypercholesterolemia
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Hypercholesterolemia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, Q2, 2011" provides data on the Hypercholesterolemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypercholesterolemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypercholesterolemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Hypercholesterolemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Hypercholesterolemia 21
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Sanofi 47
Clinical Trial Overview of Sanofi 47
Genzyme Corporation 48
Clinical Trial Overview of Genzyme Corporation 48
Takeda Global Research and Development Center, Inc 49
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 49
Abbott Laboratories 50
Clinical Trial Overview of Abbott Laboratories 50
Takeda Pharmaceutical Company Limited 51
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 51
Kowa Research Europe Ltd 52
Clinical Trial Overview of Kowa Research Europe Ltd 52
Daiichi Sankyo Company, Ltd 53
Clinical Trial Overview of Daiichi Sankyo Company, Ltd 53
Regeneron Pharmaceuticals, Inc. 54
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 54
Daiichi Sankyo, Inc. 55
Clinical Trial Overview of Daiichi Sankyo, Inc. 55
Genzyme Pharmaceuticals 56
Clinical Trial Overview of Genzyme Pharmaceuticals 56
Bristol-Myers Squibb Company 57
Clinical Trial Overview of Bristol-Myers Squibb Company 57
Kowa Company, Ltd. 58
Clinical Trial Overview of Kowa Company, Ltd. 58
Aegerion Pharmaceuticals, Inc. 59
Clinical Trial Overview of Aegerion Pharmaceuticals, Inc. 59
Santaris Pharma A/S 60
Clinical Trial Overview of Santaris Pharma A/S 60
Kowa Research Institute, Inc. 61
Clinical Trial Overview of Kowa Research Institute, Inc. 61
Soiken Inc 62
Clinical Trial Overview of Soiken Inc 62
Clinical Trial Overview of Top Universities / Institutes / Hospitals 63
University of Toronto 63
Clinical Trial Overview of University of Toronto 63
Washington University School of Medicine 64
Clinical Trial Overview of Washington University School of Medicine 64
University of Pennsylvania 65
Clinical Trial Overview of University of Pennsylvania 65
Kyoto University 66
Clinical Trial Overview of Kyoto University 66
Osaka University 67
Clinical Trial Overview of Osaka University 67
Kanazawa Medical University 68
Clinical Trial Overview of Kanazawa Medical University 68
Kumamoto University 69
Clinical Trial Overview of Kumamoto University 69
Yokohama City University 70
Clinical Trial Overview of Yokohama City University 70
University of Jena 71
Clinical Trial Overview of University of Jena 71
University Hospital, Bonn 72
Clinical Trial Overview of University Hospital, Bonn 72
University of California, San Francisco 73
Clinical Trial Overview of University of California, San Francisco 73
Stanford University 74
Clinical Trial Overview of Stanford University 74
U.S. Department of Veterans Affairs 75
Clinical Trial Overview of U.S. Department of Veterans Affairs 75
Medical University of Vienna 76
Clinical Trial Overview of Medical University of Vienna 76
University of Missouri 77
Clinical Trial Overview of University of Missouri 77
Ziv Medical Center 78
Clinical Trial Overview of Ziv Medical Center 78
The Medical University of Graz 79
Clinical Trial Overview of The Medical University of Graz 79
University of Erlangen-Nurnberg 80
Clinical Trial Overview of University of Erlangen-Nurnberg 80
University of Manitoba 81
Clinical Trial Overview of University of Manitoba 81
The National Institute of Allergy and Infectious Diseases 82
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 82
Appendix 83
Abbreviations 83
Definitions 83
Research Methodology 84
Secondary Research 84
About GlobalData 85
Contact Us 85
Disclaimer 85
Source 86




...